Finzati - Logo
ABT logo

Abbott Laboratories

ABT • Medical - Devices
$108.32
▼ -0.47 (-0.43%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$188.80B
Growth
6.8%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 14.7%Positive free cash flow · 4.23Consistent free cash flow · 5/5Manageable debt level · 0.29Healthy liquidity · 1.58
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$108.32
Change-0.43%
Shares Out1.74B
Market Cap$188.80B
Enterprise Value$215.81B
52W Range81.97 - 137.49
Beta0.61
P/E34.80
P/S4.05
P/B2.89
P/FCF21.65
EV/Sales4.63

Investment DNA

How strong this company looks for long-term investors

66
out of 100
Business Quality
Margins, moat, returns
68/100
Financial Strength
Debt, cash, stability
87/100
Growth Potential
Revenue and expansion
26/100
Price Attractiveness
Cheap or expensive today
52/100
Why this score▼
Stable or improving margins · 14.7%Positive free cash flow · 4.23Consistent free cash flow · 5/5Manageable debt level · 0.29Healthy liquidity · 1.58Negative growth trend

Analyst view

Analyst sentiment and price target

ABT
Analyst sentiment
Based on 41 analyst votes · 2026-09-05
89/100
Bullish
Bullish
32
Hold
9
Bearish
0
Price Target
2026-07-30
Low
$92.00
Mean
$123.00
Median
$120.50
High
$145.00

Company Overview

IPO: 3/17/1980
Industry: Medical - Devices
P/B i: 2.89
Debt / Equity i: 0.29
Operating Margin: 18.16%
Net Margin: 14.72%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 0.29
Current Ratio: 1.58
Quick Ratio: 1.18
Status: Strong

Insider Transactions

Recent executive and insider activity

Morrone Louis H.
Transaction: 06/30/2026
SELL
Change
-269
Price
$92.71
Filing
07/01/2026
Type
SELL
Ahuja Nita
Transaction: 06/30/2026
BUY
Change
+347
Price
Not reported
Filing
07/01/2026
Type
BUY
Conroy Kevin T
Transaction: 06/30/2026
BUY
Change
+231
Price
Not reported
Filing
07/01/2026
Type
BUY